Cargando…
Gasotransmitters: Potential Therapeutic Molecules of Fibrotic Diseases
Fibrosis is defined as the pathological progress of excessive extracellular matrix (ECM), such as collagen, fibronectin, and elastin deposition, as the regenerative capacity of cells cannot satisfy the dynamic repair of chronic damage. The well-known features of tissue fibrosis are characterized as...
Autores principales: | Chen, Yingqing, Yuan, Shuo, Cao, Yuying, Kong, Guangyao, Jiang, Feng, Li, You, Wang, Qi, Tang, Minli, Zhang, Qinggao, Wang, Qianqian, Liu, Liping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8478550/ https://www.ncbi.nlm.nih.gov/pubmed/34594474 http://dx.doi.org/10.1155/2021/3206982 |
Ejemplares similares
-
Gasotransmitter CO Attenuates Bleomycin-Induced Fibroblast Senescence via Induction of Stress Granule Formation
por: Chen, Yingqing, et al.
Publicado: (2021) -
Rhodiola rosea: A Therapeutic Candidate on Cardiovascular Diseases
por: Chen, Yingqing, et al.
Publicado: (2022) -
Gasotransmitters for the Therapeutic Prevention of Hypertension and Kidney Disease
por: Hsu, Chien-Ning, et al.
Publicado: (2021) -
Gasotransmitter-Induced
Therapeutic Angiogenesis: A
Biomaterial Prospective
por: Robert, Becky, et al.
Publicado: (2022) -
Hydrogen Sulfide as Potential Regulatory Gasotransmitter in Arthritic Diseases
por: Sunzini, Flavia, et al.
Publicado: (2020)